Authors: SATO M BRYANT HU IVERSEN P HELTERBRAND J SMIETANA F BEMIS K HIGGS R TURNER CH OWAN I TAKANO Y BURR DB

Citation: M. Sato et al., ADVANTAGES OF RALOXIFENE OVER ALENDRONATE OR ESTROGEN ON NONREPRODUCTIVE AND REPRODUCTIVE TISSUES IN THE LONG-TERM DOSING OF OVARIECTOMIZEDRATS, The Journal of pharmacology and experimental therapeutics, 279(1), 1996, pp. 298-305